Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 5 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Test Might Predict Which Kids Will Outgrow Peanut Allergy
Alaska Superstation· 18 hours agoAbout a third of young children who are allergic to peanuts will outgrow the allergy by the age of...
There's a new highly transmissible COVID-19 variant: Could FLiRT lead to a summer uptick?
Medical Xpress· 12 hours agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter's...
How antibody levels can predict which children will outgrow their peanut allergy
Medical Xpress· 4 days agoThe research, led by Murdoch Children's Research Institute (MCRI) in Melbourne and published in...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 23 hours agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 6 days agoIn addition, we seek to bolster growth through the expansion of insurance coverage in our higher value specialty segments of oncology and urology, with...
New 'FLiRT' COVID-19 Variants Are Responsible For 25% Of Infections
Women's Health via Yahoo News· 5 days agoUnfortunately, a COVID-19 test won't tell you exactly which variant is responsible for your...
HTRA1 interacts with SLC7A11 to modulate colorectal cancer chemosensitivity by inhibiting...
Nature· 21 hours agoChemotherapy is an important therapuetic strategy for colorectal cancer (CRC), but chemoresistance severely affects its efficacy, and the underlying mechanism has not been fully elucidated.
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing...
Digital Journal· 5 days ago...annually in the US 1 , yet up to two-thirds of patients fail therapy, largely due to unoptimized dosing. 2 PredictrPK is a clinically useful and cost-effective tool to help optimize biologic treatment and prevent unnecessary patient suffering, flares, surgeries, and hospitalizations. 3,4...
FDA Publishes Final Rule on Regulation of Lab-Developed Tests | JD Supra
JD Supra· 21 hours agoOn May 6, 2024 the FDA published its much-anticipated Final Rule1 on Lab-Developed Tests (“LDTs”) to make explicit that in vitro diagnostic products (“IVDs”) are devices under the Federal Food ...